Image 1 (0ab7825b C92c 45e2 Abaa Cb115564b312 01)
Frovatriptan Tablet, Film Coated
Product Images NDC 50742-299
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Frovatriptan (NDC 50742-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 2 (0ab7825b C92c 45e2 Abaa Cb115564b312 02)
This appears to be a table showing the estimated probability of response of Frovatriptan Succinate Tablets in comparison to a placebo over a period of time from the initial dose. The table shows the probability of response starting from 100% and decreasing in 10% increments down to 0%. Time from the initial dose is shown as the only column next to the probability percentages. The dosage of Frovatriptan Succinate Tablets is mentioned to be 2.5 mg.*
Image 3 (0ab7825b C92c 45e2 Abaa Cb115564b312 03)
This is a chart displaying the estimated probability of remedication or rescue for placebo and Frovatriptan Succinate Tablets 2.5 mg over a period of 24 hours, with time intervals of 4 hours. The probability starts at 100% and gradually decreases every 10% until it reaches 0%.*
Image 4 (0ab7825b C92c 45e2 Abaa Cb115564b312 04)
Blister Label (0ab7825b C92c 45e2 Abaa Cb115564b312 05)
This is a product label for Frovatriptan Succinate, a tablet medication used to treat migraines. The tablets are available in 2.5 mg dosage strength and are manufactured by Ingenus. The lot number and expiration date are listed on the label. There is also a mention of a higher strength tablet at 25 mg dosage.*
Carton Label (0ab7825b C92c 45e2 Abaa Cb115564b312 06)
Bugz is a medication in tablet form that contains 3.91 g of frovatriptan succinate, equal to 2.5 mg of frovatriptan, designed to relieve migraines. It is important to keep this medicine out of reach of children and store it at 25°C, excursions permitted to 15°-30°C. The medication is produced by Ingenus Pharmaceuticals, LLC, in India and is packaged in a blister card containing 9 tablets. The neutral code is DRUGS/AP/01/2006, and there is additional miscellany, but the output is unreadable.*
Image (0ab7825b C92c 45e2 Abaa Cb115564b312 113 2)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
